RUA Life Sciences (LON:RUA) Shares Down 2.3% – Should You Sell?

RUA Life Sciences plc (LON:RUAGet Free Report)’s stock price fell 2.3% on Thursday . The company traded as low as GBX 10.33 ($0.13) and last traded at GBX 10.75 ($0.13). 58,655 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 483,687 shares. The stock had previously closed at GBX 11 ($0.14).

RUA Life Sciences Stock Performance

The company has a current ratio of 9.01, a quick ratio of 7.32 and a debt-to-equity ratio of 5.42. The company’s 50 day moving average is GBX 11.11 and its 200-day moving average is GBX 11.50. The company has a market capitalization of £6.93 million, a P/E ratio of -279.33 and a beta of 1.21.

About RUA Life Sciences

(Get Free Report)

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.

Further Reading

Receive News & Ratings for RUA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RUA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.